Connect with us

CBD

Teva makes first foray into medical cannabis sector, with new distribution deal

Published

on

Israel’s Teva Pharmaceutical Industries, one of the world’s largest generic drug companies, is taking its first steps into the medical cannabis industry. On Sunday, the pharmaceutical giant announced that it had signed a new agreement with Cannbit-Tikun Olam, the largest medical cannabis supplier in Israel, to market and distribute medical cannabis products in Israel and the Palestinian Authority, and in the near future in Ukraine .

Under the agreement, Cannbit-Tikun Olam will produce medicinal cannabis oils that are rich in THC, the main psychoactive compound in cannabis, and CBD (cannabidiol), a compound lacking the psychoactive component and used in natural medicines. The oils will be based on cannabis strains developed by the Israeli company and selected by Teva who will then market them under a new joint brand.

The oils are processed according to the drug manufacturer’s “instructions and strict standards”, the companies said.

Teva Israel and Cannbit-Tikun Olam said they will initially work together for a period of 10 years, with the option to extend for an additional nine years.

Avinoam Sapir, general manager of Cannbit-Tikun Olam, who previously served as CEO of Teva Israel from 2013-2020, told the Times of Israel on Sunday that the agreement was “a huge, important deal” and a vote of confidence in Teva Israel’s emerging medical cannabis sector.

Sign up for the Tech Israel Daily
and never miss Israel’s top tech stories

By registering, you agree to the terms and conditions

“Teva is a huge brand and the cannabis market is a huge potential market for them. To be players in this arena, they will have another medical cannabis brand with Cannbit-Tikun Olam, ”he said.

Sapir said the medical cannabis industry in Israel is a developing market that will hit NIS 1.2 billion ($ 390 million) in 2021, up from NIS 700 million ($ 224 million) last year.

“We already have around 100,000 patients [in Israel] get medical cannabis regularly, ”said Sapir. He hopes to start distributing the oils with Teva by the first half of 2022.

Illustrative. The process of making oil from cannabis plants. (Chen Galili)

Sapir said that while medical cannabis is not yet legal in the Palestinian Authority, there have been ongoing discussions with Palestinian health authorities to allow the use of medicinal cannabis “for specific therapeutic effects such as autism and pain and various disorders”.

He estimated the Palestinian Authority market at around 50,000 patients.

The market in Ukraine with a population of 45 million people has “huge potential”, but “it depends on how they are legalized” [medical cannabis]”Said Sapir.

“We are proud of Teva Israel’s vote of confidence in selecting us as a strategic partner for Teva’s entry into the medical cannabis products market. I believe this is one of the most important industry agreements in Israel in recent years and will position Cannbit-Tikun Olam and Teva Israel as leading players in the ever growing and developing medical cannabis market in Israel and worldwide. “Said Sapir in the announcement.

“The medical cannabis arena is developing and professionalizing at a dizzying pace in Israel, and there is more openness to it in Israel and around the world,” said Yossi Ofek, CEO of Teva Israel.

“Today, it is clear to many in the pharmaceutical industry and the medical community that the use of oils made from certain cannabis strains can provide additional treatment options and respond to unmet medical needs of patients,” said Ofek.

Sapir said that Cannbit-Tikun Olam (a merged company following Cannbit’s acquisition of Tikun Olam in 2019) participated in 35 clinical trials of its cannabis strains during 2021 to find treatments for various conditions including Crohn’s disease, epilepsy and Symptoms to test for autism in children.

The deal between Cannbit and Tikun Olam came two weeks after US pharmaceutical giant Pfizer made a big bet on medicinal cannabis with its proposed acquisition of clinical-phase Arena Pharmaceuticals for a total of around $ 6.7 billion .

Cannabis in Israel

The use of medical cannabis has been legal for patients with serious illnesses in Israel since the 1990s, but over the past decade the number of users has grown exponentially as the drug gained widespread political and public support. Israel has become a global leader in the cultivation and research of medicinal cannabis as doctors prescribe cannabis to help with a range of physical, mental and emotional disorders including PTSD, gastrointestinal disorders, palliative end-of-life care, chronic pain and epilepsy.

Patients must apply for a license to use medicinal cannabis, which they can obtain through pharmacies. According to the Israeli Medical Cannabis Agency (IMCA), which operates under the auspices of the Israeli Ministry of Health, 108,013 licenses were issued in Israel by November 2021, up from 104,907 in October. In February of this year just over 94,000 licenses had been issued.

A worker looks after cannabis plants at a Tikun Olam plant near the northern Israeli city of Safed. (Abir Sultan / Flash 90)

“The rate at which the number of patients in Israel is increasing is dramatic,” said Sapir.

He also pointed out that the deal with Teva Israel will initially focus on oils, but the opportunities are huge. Medical cannabis, said Sapir, is “a very good and effective drug” amid a growing body of studies showing its benefits.

Recreational use of cannabis is currently illegal in Israel, despite the fact that the Ministry of Public Security partially decriminalized it in 2017, imposing fines and treatment for first-time offenders instead of criminal proceedings.

In June, a bill to decriminalize the recreational use of cannabis could not be voted in the Knesset plenary due to opposition from the legislators of the coalition’s Islamist Ra’am party.

A new version of the law has been drafted that would bring about major reforms in the medical cannabis industry in Israel and make it easier to access without decriminalizing recreational use. This law was subjected to a preliminary reading in the Knesset in October, with Ra’am’s support.

Under the terms of the bill, those licensed by the Ministry of Health are allowed to legally grow, distribute and possess cannabis for medicinal purposes. The new legislation aims to overcome a chronic shortage of medicinal cannabis, which is available to prescription only due to strict regulations for manufacturers.

Earlier this month, the Ministry of Health said it had set up a committee to look into the effects of banning substances or products containing CBD from the list of dangerous drugs.

The ministry said it would look into the possibility of removing CBD from the list, which means it would be possible to market products containing the active ingredient in Israel, with an emphasis on oral and topical consumption. The committee will also examine all potential benefits of products containing CBD and review the testing and monitoring processes.

The Knesset approved the formation of a cannabis committee in December, spearheaded by New Hope MK Sharren Haskel, to investigate further legalization and other cannabis-related issues.

Yaakov Schwartz and TOI staff contributed to this report.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD

The Cannabis Renaissance

Published

on

His stigma seems to be fading fast on Indian soil. From a drug provocateur to an alternative cure for creaky joints, insomnia, anxiety and other urban health disorders, cannabis has finally arrived in a sophisticated avatar packaged in essential oils. It has become a #shelfiegoal2022 to have a healing potion powered by CBD oil to get rid of your health problems. Hemp products have clearly overcome the hump of misgivings and misunderstandings on the alternative medicine bandwagon. The cannabis economy is growing.

The medicinal properties of the plant find specific mention in ancient Vedic literature. The Atharva-Veda describes cannabis as a remedy for many diseases. The Sushruta Samhita, dated between the 3rd and 8th centuries BC. BC, advocated the use of cannabis for phlegm and diarrhea. Yet with our shared perception of ganja on the ghats, clay chillums being passed around in puffs of smoke, and hashish conquering the senses, the country has quietly continued, often with, the “psychoactive” cultivation of hemp, a cousin of marijuana religious and medical accents.

Acceptance of the versatile hemp is finally gaining well-deserved ground as cannabis-powered wellness products are sold online and become best-sellers in the industry. “When we started, we had to explain why wearing a hemp shirt doesn’t get you high. Today, people of all generations buy our products and choose to heal themselves holistically through a natural source,” says Yash Kotak, co-founder of Mumbai-based BOHECO Bombay Hemp Company.

Awshad Full Spectrum Vijaya Oil Tulsi

Cannabis offers therapeutic healing and nutrition, and with over 25,000 ways to use this one plant, it’s a solution provided by the most sustainable and eco-friendly resource. “This is definitely just the beginning. We still have many miles to unlock the potential, and with the right kind of R&D practices, the world is at our feet,” says Chirag Tekchandaney, co-founder of BOHECO, adding: “In the last two years, the Income from operations increased by over 25 percent. Before that, we were operating at a three-year compound annual growth rate (CAGR) of 93 percent. The Hemp Fiber and Hemp Seed segments are expected to register substantial CAGRs of 27 percent and 25 percent, respectively, during the forecast period.

The cumulative share of these two segments was 47.6 percent in 2019 and is expected to reach 50.1 percent by 2027. We also export our products to over 10 countries, but most of our D2C audience is from India. Our repeat purchase is highest in this category, with over 43 percent of our target audience coming back to buy more. That says a lot.” This sudden shift has been evident since the lockdowns, leading to more startups in this space. Cannabis has now gained more acceptance, reaching an overtone of “herbal” overtones compared to the source of high it was once labeled as.

There was a time when the arrival at home of a CBD oil-infused supplement freaked out our loved ones. They thought we were on drugs. Now the same people are using it for its many therapeutic purposes. There has been an overall softening of attitude. Nowadays, more players encounter Boomtown. “The growth rate of this industry is directly related to the awareness of the legality, availability and benefits of this plant,” says Richa Jaggi, co-founder of Awshad, which started last year. “I believe this softening of attitudes can be directly linked to the growing popularity of cannabis around the world. Countries like the US and Canada started the cannabis destigmatization movement and funded various research to learn more about it.

They uncovered two things: the plant has various medicinal properties, and its properties were misrepresented,” she adds. Obviously learning is spreading. Loveena Sirohi, Co-Founder and Director of India Hemp Organics based in Bengaluru says: “At IHO, our growth rate has been 200 percent year over year. We have seen a diverse age range of people incorporating hemp and cannabis products into their lifestyle. Today our oldest patient is 94 years old and consumes the Sleep Well CannaBliss oil daily for better sleep.” She adds: “With the outbreak of Covid-19, cannabis-based medicinal oils helped fight a variety of diseases, including Depression and anxiety that increased during lockdown.”

The format and application of the products advertise to a cross-section of the population through oils, balms and creams. “They’re used to treat pain, inflammation, arthritis, pimples, eczema, itchy skin, and more,” says Jaggi, adding, “Cannabis edibles like tinctures and gummies are more geared towards men and women over the age of 18 who are.” suffering from insomnia, stress, anxiety, chronic pain, bowel problems, etc. People suffering from epilepsy or undergoing chemotherapy swear by this product.” alive and well the natural way the right way. But a word of caution: Cannabis leaf falls under a Schedule E-1 drug under the Drugs and Cosmetics Rules of 1945, and any medication containing a Schedule E-1 substance must be taken under medical supervision.

THE HOLY TRUTH

✥ Look for the licensed stamp of the Ministry of AYUSH, Government of India on the products
✥ Cannabis-infused medicines are safe to use and non-addictive, especially when taken under medical supervision
✥ The expensive labels are due to the difficult supply chain as hemp is mainly grown in Uttarakhand in the foothills of the Himalayas

Continue Reading

CBD

The Cannabis Renaissance- The New Indian Express

Published

on

Express Message Service

His stigma seems to be fading fast on Indian soil. From a drug provocateur to an alternative cure for creaky joints, insomnia, anxiety and other urban health disorders, cannabis has finally arrived in a sophisticated avatar packaged in essential oils. It has become a #shelfiegoal2022 to have a healing potion powered by CBD oil to get rid of your health problems. Hemp products have clearly overcome the hump of misgivings and misunderstandings on the alternative medicine bandwagon. The cannabis economy is growing.

The medicinal properties of the plant find specific mention in ancient Vedic literature. The Atharva-Veda describes cannabis as a remedy for many diseases. The Sushruta Samhita, dated between the 3rd and 8th centuries BC. BC, advocated the use of cannabis for phlegm and diarrhea. Yet with our shared perception of ganja on the ghats, clay chillums being passed around in puffs of smoke, and hashish conquering the senses, the country has quietly continued, often with, the “psychoactive” cultivation of hemp, a cousin of marijuana religious and medical accents.

Acceptance of the versatile hemp is finally gaining well-deserved ground as cannabis-powered wellness products are sold online and become best-sellers in the industry. “When we started, we had to explain why wearing a hemp shirt doesn’t get you high. Today, people of all generations buy our products and choose to heal themselves holistically through a natural source,” says Yash Kotak, co-founder of Mumbai-based BOHECO Bombay Hemp Company.

Awshad Full Spectrum Vijaya Oil Tulsi

Cannabis offers therapeutic healing and nutrition, and with over 25,000 ways to use this one plant, it’s a solution provided by the most sustainable and eco-friendly resource. “This is definitely just the beginning. We still have many miles to unlock the potential, and with the right kind of R&D practices, the world is at our feet,” says Chirag Tekchandaney, co-founder of BOHECO, adding: “In the last two years, the Income from operations increased by over 25 percent. Before that, we were operating at a three-year compound annual growth rate (CAGR) of 93 percent. The Hemp Fiber and Hemp Seed segments are expected to register substantial CAGRs of 27 percent and 25 percent, respectively, during the forecast period.

The cumulative share of these two segments was 47.6 percent in 2019 and is expected to reach 50.1 percent by 2027. We also export our products to over 10 countries, but most of our D2C audience is from India. Our repeat purchase is highest in this category, with over 43 percent of our target audience coming back to buy more. That says a lot.” This sudden shift has been evident since the lockdowns, leading to more startups in this space. Cannabis has now gained more acceptance, reaching an overtone of “herbal” overtones compared to the source of high it was once labeled as.

There was a time when the arrival at home of a CBD oil-infused supplement freaked out our loved ones. They thought we were on drugs. Now the same people are using it for its many therapeutic purposes. There has been an overall softening of attitude. Nowadays, more players encounter Boomtown. “The growth rate of this industry is directly related to the awareness of the legality, availability and benefits of this plant,” says Richa Jaggi, co-founder of Awshad, which started last year. “I believe this softening of attitudes can be directly linked to the growing popularity of cannabis around the world. Countries like the US and Canada started the cannabis destigmatization movement and funded various research to learn more about it.

They uncovered two things: the plant has various medicinal properties, and its properties were misrepresented,” she adds. Obviously learning is spreading. Loveena Sirohi, Co-Founder and Director of India Hemp Organics based in Bengaluru says: “At IHO, our growth rate has been 200 percent year over year. We have seen a diverse age range of people incorporating hemp and cannabis products into their lifestyle. Today our oldest patient is 94 years old and consumes the Sleep Well CannaBliss oil daily for better sleep.” She adds: “With the outbreak of Covid-19, cannabis-based medicinal oils helped fight a variety of diseases, including Depression and anxiety that increased during lockdown.”

The format and application of the products advertise to a cross-section of the population through oils, balms and creams. “They’re used to treat pain, inflammation, arthritis, pimples, eczema, itchy skin, and more,” says Jaggi, adding, “Cannabis edibles like tinctures and gummies are more geared towards men and women over the age of 18 who are.” suffering from insomnia, stress, anxiety, chronic pain, bowel problems, etc. People suffering from epilepsy or undergoing chemotherapy swear by this product.” alive and well the natural way the right way. But a word of caution: Cannabis leaf falls under a Schedule E-1 drug under the Drugs and Cosmetics Rules of 1945, and any medication containing a Schedule E-1 substance must be taken under medical supervision.

THE HOLY TRUTH

✥ Look for the licensed stamp of the Ministry of AYUSH, Government of India on the products
✥ Cannabis-infused medicines are safe to use and non-addictive, especially when taken under medical supervision
✥ The expensive labels are due to the difficult supply chain as hemp is mainly grown in Uttarakhand in the foothills of the Himalayas

Continue Reading

CBD

RESET Bioscience Debuts Bioavailable Pet CBD Drops

Published

on

AUSTIN, Texas, Jan. 13, 2022 /PRNewswire/ — RESET Bioscience, an advanced wellness company utilizing pharmaceutical-grade ingredients and technology, is introducing CBD drops for pets to its portfolio.

Developed by leading Ph.D. Scientists are RESET Pet CBD Drops the world’s first water-based ingestible CBD for pets Powered by Santé® Delivery Technology for fast, maximum absorption and double tested to human standards.

The same lipid encapsulation technology that pioneered RESET’s wellness products is now being applied to pet products. RESET’s highly bioavailable drops can be conveniently added to your pet’s food, favorite treat or even your pet’s water bowl with no separation required as the formula is water based.

“As a proud mommy of dogs, my pets are an extension of my family and their health and well-being are of the utmost importance,” said Ashley Ferguson, President of RESET. “I wanted to use CBD pet treats to support my elderly Chihuahua’s quality of life and calm my anxious Doberman puppy at home. Before introducing RESET, I tested treats and oils from major brands on the market at a leading analysis lab. I was beyond shocked and disappointed to find alarming levels of heavy metals like lead, mercury and even arsenic, residual solvents and microbiological contaminants like E. coli and salmonella in almost every product. that I was recommended to dose my Chihuahua the same amount as my Doberman!

We immediately felt compelled to bring to market a pet product with human ingredients protected by our world-class testing and saw an opportunity to apply RESET’s delivery system in partnership with Powered by Santé® Deployment Technology. Technology differentiates RESET Pet by providing faster, better absorption for more immediate results and safer dosing in accordance with a pet’s weight. With this water-based formula, pet parents can have peace of mind at any dosage, while with oils you risk liver toxicity as small livers do not process oil well. We are constantly focused on the next generation of wellness and are proud to extend this to animal health.”

Like humans, cats and dogs can take full advantage of the interaction between CBD and the endocannabinoid system. Because of this, CBD can have positive effects on everything from mood, to mind and body support, to general well-being. RESET is thrilled to offer ecommerce shoppers award-winning CBD relief for their furry friends.

RESET’s latest advancement features traceable premium ingredients that are lab tested to ensure potency, purity and consistency. Designed for maximum bioavailability, Pet CBD Drops come in a pet-approved pumpkin flavor to wag those tails!

About RESET Pet CBD Drops:

  • 5 mg highly bioavailable CBD per 0.5 ml, 150 mg per bottle
  • Hemp-derived cannabidiol (CBD) extracted from premium hemp grown in the USA. THC-free (tested less than 0.001% THC)
  • Contains a delimited dropper for accurate and precise dosing
  • Laboratory tested to ensure potency, purity and consistency
  • Safety sealed to protect your pet. Store at room temperature with the bottle closed
  • Made in the USA

RESET Pet CBD Drops can be added to your pet’s water, food, or favorite treat, but RESET suggests avoiding dropper contact with snoots. With user-friendly dosing based on pet weight, pet owners can be confident in the amount of CBD being administered to their pets.

For more information about RESET Pet CBD Drops, please visit RESETbioscience.com and follow @RESETbioscience on Instagram, TikTok and Facebook.

About RESET: RESET products with Powered by Santé® Delivery Technology, empowers you to RESET your wellness ritual with powerful solutions that support you from dawn to dusk. Engineered for maximum bioavailability of premium ingredients and uniquely water-based, like your body, RESET products are expertly blended by Ph.D. Scientists need to go where you need it (in your small intestine) so you can actually absorb it. Inspired by nature and backed by science, their line of wellness products is formulated and tested to pharmaceutical standards and proven to last over 12 months.

Current awards:

*Tested for less than 0.001% THC

View original content: https://www.prnewswire.com/news-releases/reset-bioscience-debuts-bioavailable-pet-cbd-drops-301460773.html

RESET SOURCE Life Sciences

Continue Reading
Advertisement

Trending